Diversified science and technology company Danaher (NYSE:DHR) fell short of the market’s revenue expectations in Q1 CY2026 as ...

The single-use bioprocessing market offers significant growth opportunities, driven by the demand for enhanced productivity, flexibility, and cost-efficiency. Asia-Pacific is emerging as a key growth ...

| Bioprocessing is evolving rapidly in a shifting landscape of innovative and complex products, processes and technologies.

Introducing CPC Biotech - one brand uniting critical fluid management components New brand unites CPC’s Biopharma connector ...

At INTERPHEX 2026, David Chau and Stuart Tindal discuss automation, single-use durability challenges, and the shift to ...

Bryan Poltilove, a strategic advisor and independent board director with over two decades of experience in bioprocessing and ...

Since the first monoclonal antibody (OKT3) was approved in 1986, the FDA has granted approval to more than 100 antibody-based therapeutic products, including monoclonal antibodies (mAbs), fusion ...

SaniSure has introduced PETG PharmaTainer, a bioprocessing bottle and carboy line made with medical-grade Eastman Eastar PETG ...

At the 2026 BiOS conference in San Francisco, researchers presented a biosensing platform aimed at improving how living cells and tissues are monitored during drug bioprocessing. Known as TissueSense, ...

Q1 2026 Management View "We're off to a solid start to the year... deliver better-than-expected adjusted EPS growth," said President, CEO & Director Rainer Blair, adding that "continued strength in ...

April 21 (Reuters) - Life sciences firm Danaher topped first-quarter profit expectations on Tuesday, fueled by strong demand for its bioprocessing tools used in drug manufacturing, lifting shares 2% ...

Portfolio now includes standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems ...